help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 26, 2005
Endocrinology, doi:10.1210/en.2004-1643
A more recent version of this article appeared on September 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
146/9/3975    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bielinska, M.
Right arrow Articles by Wilson, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bielinska, M.
Right arrow Articles by Wilson, D. B.

Submitted on December 21, 2004
Accepted on May 18, 2005

Gonadotropin-induced adrenocortical neoplasia in NU/J nude mice

Malgorzata Bielinska, Elena Genova, Irving Boime, Helka Parviainen, Sanne Kiiveri, Juhani Leppäluoto, Nafis Rahman, Markku Heikinheimo, and David B. Wilson*

Departments of Pediatrics (M.B., E.G., M.H., D.B.W.) and Molecular Biology & Pharmacology (I.B., D.B.W.), Washington University School of Medicine, St. Louis Children's Hospital, St. Louis, MO 63110; Children's Hospital, Program for Developmental and Reproductive Biology, Biomedicum Helsinki, University of Helsinki, 00290 Helsinki, Finland (H.P., M.H.); Department of Physiology, Institute of Biomedicine, University of Turku, 20520 Turku, Finland (N.R.); Department of Physiology, Univ. of Oulu, 90220 Oulu, Finland (J.L.)

* To whom correspondence should be addressed. E-mail: wilson_d{at}wustl.edu.

In response to prepubertal gonadectomy certain inbred mouse strains, including DBA/2J, develop sex steroid-producing adrenocortical neoplasms. This phenomenon has been attributed to a lack of gonadal hormones or a compensatory increase in gonadotropins. To assess the relative importance of these mechanisms, we created a new inbred model of adrenocortical neoplasia using female NU/J nude mice. These mice developed adrenocortical neoplasms in response to either gonadectomy or gonadotropin elevation from xenografts of hCG-secreting CHO cells. In each instance the adrenal tumors resembled the neoplasms found in gonadectomized DBA/2J mice and were composed of spindle-shaped A cells and lipid-laden B cells. Both cell populations were defined by ectopic expression of GATA-4 and an absence of the adrenocortical markers melanocortin-2-receptor and steroid 21-hydroxylase, but only B cells expressed the gonadal steroidogenic markers inhibin-{alpha}, LH receptor, P450c17, and P450c19. Expression of sex steroidogenic markers was attenuated in the neoplastic adrenal cortex of hCG-treated vs. gonadectomized mice. While neoplastic adrenals were an obvious source of estradiol in gonadectomized mice, ovaries appeared to be the major source of this hormone in hCG-treated mice. Gonadectomy and hCG-treatment elicited comparable increases in serum estradiol, but testosterone levels increased significantly only in hCG-treated mice. We conclude that chronic gonadotropin elevation, caused either by gonadectomy or hCG administration, signals a population of cells in the adrenal subcapsular region of permissive mice to undergo differentiation along a gonadal rather than an adrenal lineage. Thus, NU/J nude mice can be used as a model to study both neoplasia and adrenogonadal lineage specification.


Key words: adrenal tumor • metaplasia • ovariectomy • steroidogenesis • transdifferentiation • xenograft




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
M. Doghman, J. Cazareth, and E. Lalli
The T cell factor/{beta}-Catenin Antagonist PKF115-584 Inhibits Proliferation of Adrenocortical Carcinoma Cells
J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 3222 - 3225.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
S. Vuorenoja, A. Rivero-Muller, A. J Ziecik, I. Huhtaniemi, J. Toppari, and N. A Rahman
Targeted therapy for adrenocortical tumors in transgenic mice through their LH receptor by Hecate-human chorionic gonadotropin {beta} conjugate
Endocr. Relat. Cancer, June 1, 2008; 15(2): 635 - 648.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. D. Clugston, W. Zhang, and J. J. Greer
Gene expression in the developing diaphragm: significance for congenital diaphragmatic hernia
Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L665 - L675.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Bernichtein, E. Petretto, S. Jamieson, A. Goel, T. J. Aitman, J. M. Mangion, and I. T. Huhtaniemi
Adrenal Gland Tumorigenesis after Gonadectomy in Mice Is a Complex Genetic Trait Driven by Epistatic Loci
Endocrinology, February 1, 2008; 149(2): 651 - 661.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Doghman, T. Karpova, G. A. Rodrigues, M. Arhatte, J. De Moura, L. R. Cavalli, V. Virolle, P. Barbry, G. P. Zambetti, B. C. Figueiredo, et al.
Increased Steroidogenic Factor-1 Dosage Triggers Adrenocortical Cell Proliferation and Cancer
Mol. Endocrinol., December 1, 2007; 21(12): 2968 - 2987.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
B. D. Looyenga and G. D. Hammer
Origin and Identity of Adrenocortical Tumors in Inhibin Knockout Mice: Implications for Cellular Plasticity in the Adrenal Cortex
Mol. Endocrinol., November 1, 2006; 20(11): 2848 - 2863.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
I. K Johnsen, M. Slawik, I. Shapiro, M. F Hartmann, S. A Wudy, B. D Looyenga, G. D Hammer, M. Reincke, and F. Beuschlein
Gonadectomy in mice of the inbred strain CE/J induces proliferation of sub-capsular adrenal cells expressing gonadal marker genes.
J. Endocrinol., July 1, 2006; 190(1): 47 - 57.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
M Anttonen, H Parviainen, A Kyronlahti, M Bielinska, D B Wilson, O Ritvos, and M Heikinheimo
GATA-4 is a granulosa cell factor employed in inhibin-{alpha} activation by the TGF-{beta} pathway.
J. Mol. Endocrinol., June 1, 2006; 36(3): 557 - 568.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society